CAS No. |
782500-75-8 |
|---|---|
中文名称 |
(4S,7S,10R,13R,16S,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,58S)-4-(((6S,12S,15S,18S,21S,24R,27S,30S)-21-((1H-吲哚-3-基)甲基)-1-氨基-12-(4-氨基丁基)-27-((R)-仲丁基)-6-氨甲酰基-1-亚氨基-18-异丁基-15-异丙基-24-甲基-8,11,14,17,20,23,26,29-八氧代-31-苯基-2,7,10,13,16,19,22,25,28-九氮杂三十一烷-30-基)氨甲酰基)-58-(2-((S)-2-氨基-3-(1H-咪唑-5-基)丙酰胺基)乙酰胺基)-16-(3-氨基-3-氧代丙基)-7-(4-氨基丁基)-49-苄基-22-(2-羧乙基)-40-(羧甲基)-28-(4-羟基苄基)-46,52-双((S)-1-羟乙基)-31,34,43-三(羟甲基)-25-异丁基-37-异丙基-10,13-二甲基-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-十八氧代-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-十八氮杂六十六烷二酸 |
英文名称 |
(4S,7S,10R,13R,16S,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,58S)-4-(((6S,12S,15S,18S,21S,24R,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(4-aminobutyl)-27-((R)-sec-butyl)-6-carbamoyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-yl)carbamoyl)-58-(2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)acetamido)-16-(3-amino-3-oxopropyl)-7-(4-aminobutyl)-49-benzyl-22-(2-carboxyethyl)-40-(carboxymethyl)-28-(4-hydroxybenzyl)-46,52-bis((S)-1-hydroxyethyl)-31,34,43-tris(hydroxymethyl)-25-isobutyl-37-isopropyl-10,13-dimethyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-octadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-octadecaazahenhexacontanedioic acid |
别名 |
UNII-5E7U48495E | GSK716155 | S3734 | Albugon | Eperzan | 5E7U48495E | Albiglutide | HSDB 8282 | tanzeum | PD078276 | GSK 716155 | Albiglutide [USAN:INN] |
标准英文名 |
(4S,7S,10R,13R,16S,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,58S)-4-(((6S,12S,15S,18S,21S,24R,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(4-aminobutyl)-27-((R)-sec-butyl)-6-carbamoyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-yl)carbamoyl)-58-(2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)acetamido)-16-(3-amino-3-oxopropyl)-7-(4-aminobutyl)-49-benzyl-22-(2-carboxyethyl)-40-(carboxymethyl)-28-(4-hydroxybenzyl)-46,52-bis((S)-1-hydroxyethyl)-31,34,43-tris(hydroxymethyl)-25-isobutyl-37-isopropyl-10,13-dimethyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-octadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-octadecaazahenhexacontanedioic acid |
MDL No. |
MFCD27976663 |
分子式 |
C148H224N40O45 |
分子量 |
3283.66 |
精确分子量 |
3281.65 |
SMILES |
CC[C@@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C |
标准SMILES |
CC[C@@H](C)[C@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O |
用途 |
Albiglutide is a long-acting GLP-1 receptor agonist used for the treatment of type 2 diabetes mellitus; it promotes insulin secretion by activating the GLP-1 receptor and has demonstrated superior glycemic control compared to sitagliptin and exenatide. |
InChIKey |
JYDZPPZAYQTOIV-OTSUTHPESA-N |
|
|
评论 |
|---|